CRIS Curis, Inc.
Healthcare$0.49-1.40%ClosedMarket Cap: $6.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
7.64
P/S
0.93
EV/EBITDA
0.95
DCF Value
$-0.29
FCF Yield
-438.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
99.4%
Operating Margin
-485.1%
Net Margin
-299.7%
ROE
805.7%
ROA
-71.3%
ROIC
-259.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-11.5M | $-24.2M | $— | — |
| Q4 null | $1.1M | 100.0% | $-7.6M | $19.4M | $— | — |
| FY null | $9.4M | 99.5% | $-32.9M | $-7.6M | $— | — |
| Q3 null | $3.2M | 99.5% | $-6.9M | $-7.7M | $— | — |
| Q2 null | $2.7M | 99.4% | $-8.3M | $-8.6M | $— | — |
| Q1 null | $2.4M | 99.4% | $-10.2M | $-10.6M | $— | — |
| Q4 null | $3.3M | 99.5% | $-9.0M | $-9.6M | $— | — |
| FY null | $10.9M | 99.1% | $-44.5M | $-43.4M | $— | — |
| Q3 null | $2.9M | 99.2% | $-10.6M | $-10.1M | $— | — |
| Q2 null | $2.5M | 99.5% | $-12.5M | $-11.8M | $— | — |
| Q1 null | $2.1M | 97.7% | $-12.5M | $-11.9M | $— | — |
| Q4 2023 | $2.7M | 98.0% | $-12.2M | $-11.7M | $-2.04 | — |